This study showed that patients with active IBD are characterized by elevated levels of standard inflammatory markers (including CRP and calprotectin), reduced albumin levels, and a higher prevalence of fluctuations in body weight, including both weight loss and excess weight gain, compared with patients with inactive IBD. This evidence concerns the gene CRP and irritable bowel syndrome.